Characterized by an airflow limitation in the respiratory airways, chronic obstructive pulmonary disease (COPD) is the result of chronic bronchial inflammation.
The main symptom of COPD is breathlessness, which becomes more pronounced over time, contributing to a further respiratory handicap. It is accompanied by chronic coughing and sputum production. Tobacco smoke is the major factor of COPD1-2-5, although indoor and outdoor air pollution and exposure to pollutants in the workplace are also risk factors.
people affected by COPD around the world
COPD is the third leading cause of death worldwide
COPD affects 210 million people around the world3. According to the World Health Organization, COPD is the third leading cause of death worldwide, after coronary heart disease and stroke4.
210 million people affected around the world
Acute exacerbation episodes and prolonged worsening of symptoms mark the development of the disease and accelerate the decline of the respiratory function. COPD is sometimes diagnosed during one of these exacerbation episodes.
The therapeutic strategy consists in controlling the symptoms, reducing the frequency and severity of exacerbation episodes and lowering the risks of hospitalization1-2 using the following measures:
Ending all exposure to tobacco or other pollutants is the prime recommendation
Some medications contribute to reduce inflammation and dilate the airways
Flu and pneumococcal vaccinations help preventing intensification episodes
Rehabilitation exercises help improving the physical capacity to fight the disease
Many COPD patients with chronic respiratory failure also benefit from long-term oxygen therapy1 and/or nocturnal ventilation4
Our commitment to patient quality of life
Together with healthcare professionals, the teams at Air Liquide Healthcare are working to develop and facilitate home healthcare services for patients with severe COPD who need respiratory assistance.
The main stake of providing this care is to improve the patient quality of life by ensuring the compliance of the treatment.
When prescribed by a physician, the home healthcare service provider supplies patients who suffer from associated respiratory failure with oxygen therapy and/or ventilation tailored to their individual needs. The service provider is committed to the patient to prevent exacerbations and control the progress of COPD for a better quality of life.
Throughout the treatment period, the home healthcare service provider works with prescribing physicians to support patients, help them understand their illness and complete their treatment while reinforcing the compliance.
Köhnlein T, Windisch W, Köhler D ans al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med 2014 ;2(9) :698-705. Available at <DOI: 10.1016/S2213-2600(14)70153-5>